Fig. 1From: Exploratory cost-effectiveness analysis of cardiac resynchronization therapy with systematic device optimization vs. standard (non-systematic) optimization: a multinational economic evaluationDeath rate with the value of the average between the actual rate and the upper confidence interval limit in the CLEAR study and CARE-HF study (patients >66 year-old), at 1 yearBack to article page